Structural Insight into the Inhibition of Human Kynurenine Aminotransferase I/Glutamine Transaminase K

Journal of Medicinal Chemistry
2009.0

Abstract

Human kynurenine aminotransferase I (hKAT I) catalyzes the formation of kynurenic acid, a neuroactive compound. Here, we report three high-resolution crystal structures (1.50-1.55 A) of hKAT I that are in complex with glycerol and each of two inhibitors of hKAT I: indole-3-acetic acid (IAC) and Tris. Because Tris is able to occupy the substrate binding position, we speculate that this may be the basis for hKAT I inhibition. Furthermore, the hKAT/IAC complex structure reveals that the binding moieties of the inhibitor are its indole ring and a carboxyl group. Six chemicals with both binding moieties were tested for their ability to inhibit hKAT I activity; 3-indolepropionic acid and DL-indole-3-lactic acid demonstrated the highest level of inhibition, and as they cannot be considered as substrates of the enzyme, these two inhibitors are promising candidates for future study. Perhaps even more significantly, we report the discovery of two different ligands located simultaneously in the hKAT I active center for the first time.

Knowledge Graph

Similar Paper

Structural Insight into the Inhibition of Human Kynurenine Aminotransferase I/Glutamine Transaminase K
Journal of Medicinal Chemistry 2009.0
Crystal Structure of theHomo sapiensKynureninase-3-Hydroxyhippuric Acid Inhibitor Complex: Insights into the Molecular Basis Of Kynureninase Substrate Specificity
Journal of Medicinal Chemistry 2009.0
Structure–activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors
European Journal of Medicinal Chemistry 2011.0
Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2
Bioorganic & Medicinal Chemistry Letters 2011.0
3-Amino-5,5-dimethylhexanoic Acid. Synthesis, Resolution, and Effects on Carnitine Acyltransferases
Journal of Medicinal Chemistry 1994.0
Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway
Journal of Medicinal Chemistry 2015.0
Structural, Mutagenic, and Kinetic Analysis of the Binding of Substrates and Inhibitors of Human PhenylethanolamineN-Methyltransferase
Journal of Medicinal Chemistry 2005.0
Substrate and inhibitor specificity of kynurenine monooxygenase from Cytophaga hutchinsonii
Bioorganic & Medicinal Chemistry Letters 2017.0
The relevance of K i calculation for bi-substrate enzymes illustrated by kinetic evaluation of a novel lysine (K) acetyltransferase 8 inhibitor
European Journal of Medicinal Chemistry 2017.0
Structure-based Design, Synthesis, Evaluation, and Crystal Structures of Transition State Analogue Inhibitors of Inosine Monophosphate Cyclohydrolase
Journal of Biological Chemistry 2007.0